32
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Commentary on pharmacotherapy of regional melanoma therapy

, MD FACS & , MD
Pages 1-3 | Published online: 10 Dec 2009

Bibliography

  • Tyler DS. Pharmacotherapy of regional melanoma therapy. Expert Opin Pharmacother 2009;11(1):79-93
  • Thompson JF, Kam PC, Waugh RC, Harman CR. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol 1998;14:238-47
  • Beasley GM, Caudle A, Petersen RP, A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg 2009;208:706-15; discussion 15-7
  • McMahon N, Cheng TY, Beasley GM, Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity? Ann Surg Oncol 2009;16:953-61
  • Santillan A, Delman KA, Beasley GM, Prognostic factors of regional and systemic toxicity after isolated limb infusion (ILI): a multi-institutional analysis. Ann Surg Oncol 2009;16:2570-8
  • Beasley GM, McMahon N, Sanders G, A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma. Cancer 2009. [Epub 27 Jul 2009]
  • Gallagher SJ, Thompson JF, Indsto J, p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors. Neoplasia 2008;10:1231-9
  • Beasley GM, Petersen RP, Yoo J, Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol 2008;15:2195-205

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.